SEGMENT INFORMATION - Segment Information Of Net Sales And Operating Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Segment Reporting Information [Line Items]
Net sales	$ 2,835	$ 2,699	$ 8,270	$ 7,883
Cost of sales	1,885	1,666	5,468	4,858
Selling, general and administrative expenses	708	754	2,129	2,206
Research and development expenses	118	129	392	379
Segment operating income	172	155	421	449
Operating Segments | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales	1,329	1,342	3,911	3,893
Cost of sales	752	734	2,201	2,136
Selling, general and administrative expenses	286	291	867	868
Research and development expenses	41	53	163	160
Other segment items	(23)	(4)	(76)	(4)
Segment operating income	273	268	756	733
Operating Segments | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales	773	752	2,244	2,167
Cost of sales	410	368	1,154	1,094
Selling, general and administrative expenses	219	203	658	612
Research and development expenses	48	45	142	138
Other segment items	(8)	0	(25)	0
Segment operating income	104	136	315	323
Operating Segments | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	632	588	1,825	1,768
Cost of sales	450	408	1,274	1,197
Selling, general and administrative expenses	107	95	316	289
Research and development expenses	26	23	77	67
Other segment items	(7)	4	(25)	4
Segment operating income	$ 56	$ 58	$ 183	$ 211